Compile Data Set for Download or QSAR
Report error Found 116 Enz. Inhib. hit(s) with Target = 'Histone lysine demethylase PHF8'
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50652775(CHEMBL4303308)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of PHF8 (1 to 1024 residues)(unknown origin) by Alphalisa assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50652776(CHEMBL4786329)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of PHF8 (1 to 1024 residues)(unknown origin) by Alphalisa assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM195611(GSKJ1)
Affinity DataIC50: 2.80nMAssay Description:Inhibition of PHF8 (1 to 1024 residues)(unknown origin) by Alphalisa assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50483927(CHEMBL3183531)
Affinity DataIC50: 4.20nMAssay Description:Inhibition of PHF8 (1 to 1024 residues)(unknown origin) by Alphalisa assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/13/2025
Entry Details
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276044(2-[1-[2-(2-chlorophenyl)ethyl]imidazol-4-yl]-4-(1H...)
Affinity DataIC50: 100nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276050(2-[1-(3,4-dihydro-2H-chromen-4-ylmethyl)imidazol-4...)
Affinity DataIC50: 100nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276067(2-[1-[(3-chloro-2-fluorophenyl)methyl]imidazol-4-y...)
Affinity DataIC50: 100nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50155449(CHEMBL3780958)
Affinity DataIC50: 250nMAssay Description:Inhibition of human PHF8 preincubated for 10 mins followed by substrate addition by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2017
Entry Details Article
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50155505(CHEMBL3781414)
Affinity DataIC50: 250nMAssay Description:Inhibition of human PHF8 preincubated for 10 mins followed by substrate addition by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2017
Entry Details Article
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50155507(CHEMBL3780904)
Affinity DataIC50: 250nMAssay Description:Inhibition of human PHF8 preincubated for 10 mins followed by substrate addition by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2017
Entry Details Article
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50155450(CHEMBL3779953)
Affinity DataIC50: 250nMAssay Description:Inhibition of human PHF8 preincubated for 10 mins followed by substrate addition by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2017
Entry Details Article
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50155509(CHEMBL3780689)
Affinity DataIC50: 250nMAssay Description:Inhibition of human PHF8 preincubated for 10 mins followed by substrate addition by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2017
Entry Details Article
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50155508(CHEMBL3780833)
Affinity DataIC50: 250nMAssay Description:Inhibition of human PHF8 preincubated for 10 mins followed by substrate addition by AlphaLISA assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/10/2017
Entry Details Article
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276057(2-[1-[(2,3-dichlorophenyl)methyl]imidazol-4-yl]-4-...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276059(2-[1-[(2,3-dichlorophenyl)methyl]imidazol-4-yl]-4-...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276058(2-[1-[(2,3-dichlorophenyl)methyl]imidazol-4-yl]-4-...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276053(4-[2-[1-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)i...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276082(1-benzyl-4-{1H-[1,2,3]triazolo[4,5-c]pyridin-6-yl}...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276054(4-[2-[1-(2-naphthalen-1-ylethyl)imidazol-4-yl]pyri...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276039(2-(1-methylimidazol-4-yl)-4-(1H-triazol-4-yl)pyrid...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276093(2-(5-bromo-1-(2-chlorobenzyl)-1H-imidazol-4-yl)-4-...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276060(2-[1-[[2-chloro-3-(trifluoromethyl)phenyl]methyl]i...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276062(2-[5-(4-fluoro-3-methoxyphenyl)-1-methylimidazol-4...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276061(2-[1-(2-naphthalen-1-ylethyl)imidazol-4-yl]-4-(1H-...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276043(2-[1-(1-phenylethyl)imidazol-4-yl]-4-(1H-triazol-4...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276070(2-[1-[2-(2-chlorophenyl)-2-methylpropyl]imidazol-4...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276073(4-(5-fluoro-1H-triazol-4-yl)-2-[1-(2-naphthalen-1-...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276072(4-(1H-triazol-4-yl)-2-[1-[2-[2-(trifluoromethoxy)p...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276040(2-[1-[(2-chlorophenyl)methyl]imidazol-4-yl]-4-(1H-...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276066(2-[1-[(2-fluoro-3-methylphenyl)methyl]imidazol-4-y...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276069(4-(1H-triazol-4-yl)-2-[1-[2-[2-(trifluoromethyl)ph...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276041(2-[5-(4-fluorophenyl)-1-methylimidazol-4-yl]-4-(1H...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276068(2-[1-[(2-fluoro-3-methoxyphenyl)methyl]imidazol-4-...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276049(2-[1-[2-[2-(cyclopropylmethoxy)phenyl]ethyl]imidaz...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276048(4-(1H-triazol-4-yl)-2-[1-[2-[2-(2,2,2-trifluoroeth...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276046(2-[1-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)imid...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276045(2-[1-[2-(2-methoxyphenyl)ethyl]imidazol-4-yl]-4-(1...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276047(2-[1-[2-(2-ethoxyphenyl)ethyl]imidazol-4-yl]-4-(1H...)
Affinity DataIC50: 300nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM50395083(CHEMBL2164246)
Affinity DataIC50: 480nMAssay Description:Inhibition of human PHF8 expressed in Escherichia coli using methyl lysine peptide substrate by AlphaScreen assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/17/2013
Entry Details Article
PubMed
TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276085(1-[(4-chlorophenyl)methyl]-4-{1H-[1,2,3]triazolo[4...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276071(2-[1-(1-phenylpropan-2-yl)imidazol-4-yl]-4-(1H-tri...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276056(2-[1-[2-(2-phenoxyphenyl)ethyl]imidazol-4-yl]-4-(1...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276086(1-[(3,4-dichlorophenyl)methyl]-4-{1H-[1,2,3]triazo...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276052(4-[2-[1-[(2,3-dichlorophenyl)methyl]imidazol-4-yl]...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276084(1-[(3-chlorophenyl)methyl]-4-{1H-[1,2,3]triazolo[4...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276042(2-[5-[2-(cyclopropylmethoxy)-4-fluorophenyl]-1-met...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276055(2-[1-[2-(2-phenylmethoxyphenyl)ethyl]imidazol-4-yl...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276083(1-[(2-chlorophenyl)methyl]-4-{1H-[1,2,3]triazolo[4...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276091(5-(4-fluorophenyl)-1-methyl-4-{1H-[1,2,3]triazolo[...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

TargetHistone lysine demethylase PHF8(Human)
EpiTherapeutics Aps

Curated by ChEMBL
LigandPNGBDBM276063(2-[5-(3-ethoxy-4-fluorophenyl)-1-methylimidazol-4-...)
Affinity DataIC50: 500nMAssay Description:PHF8 Assay: The ability of test compounds to inhibit the activity of PHF8 was determined in 384-well plate format under the following reaction condit...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/21/2020
Entry Details
US Patent

Displayed 1 to 50 (of 116 total ) | Next | Last >>
Jump to: